Literature DB >> 30284302

A paired trial comparing mononuclear cell collection in two machines for further inactivation through an inline or offline extracorporeal photopheresis procedure.

José-Luis Bueno1, Rosalía Alonso1, Clara Gonzalez-Santillana1, Daniel Naya1, Irene Romera1, Ana Alarcón1, Myriam Aguilar2, Guiomar Bautista1, Rafael Duarte1, Piedad Ussetti2, José Rafael Cabrera1.   

Abstract

BACKGROUND: Extracorporeal photopheresis (ECP) is an effective treatment. However, protocols differ widely, and some questions, such as the number of cells to be collected or the number of ECP treatment days per treatment cycle, are still unsolved. The aim of this study was to compare a multistep (offline) (Spectra Optia and Macogenic G2) against an integrated (inline) ECP system (Therakos Cellex system) with respect to mononuclear cell (MNC) collection. STUDY DESIGN AND METHODS: The number and quality parameters of the MNC products collected were evaluated together with some machine parameters, such as collection time. Comparisons were made through paired sample analysis with the t test.
RESULTS: Fourteen patients underwent 15 double-paired procedures using both ECP protocols. The average MNC collected in the multistep procedure was 77.4 × 108 , four times more than in the integrated procedure (18.5 × 108 ). MNC purity (84.4% vs. 63.8%) and enrichment (27.9 vs. 5.9) in the product collected were also higher in the multistep procedure. The whole ECP time was higher in the multistep than in the integrated procedure (272 vs. 106 min), but the calculated time to collect 25 × 108 MNCs in the multistep was shorter compared with the one-step procedure (77.8 vs. 172 min). All these differences between the two protocols were statistically significant.
CONCLUSIONS: These two ECP protocols are different with respect to MNC collection and length of procedure. Some unresolved questions, such as the better MNC dose to inactivate or the number of consecutive days that ECP should be performed for optimal clinical efficacy, require further review.
© 2018 AABB.

Entities:  

Mesh:

Year:  2018        PMID: 30284302     DOI: 10.1111/trf.14975

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Does Offline Beat Inline Treatment: Investigation into Extracorporeal Photopheresis.

Authors:  Wolfgang Helmberg; Sabine Sipurzynski; Andrea Groselje-Strehle; Hildegard Greinix; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2020-03-27       Impact factor: 3.747

2.  A standardized methodical approach to characterize the influence of key parameters on the in vitro efficacy of extracorporeal photopheresis.

Authors:  Marie Laulhé; Sylvie Lefebvre; Delphine Le Broc-Ryckewaert; Maxime Pierre; Aurélie Ferry; Bruno Delorme
Journal:  PLoS One       Date:  2019-03-01       Impact factor: 3.240

3.  Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease.

Authors:  Katherine Radwanski; Edwin Burgstaler; Jennifer Weitgenant; Heather Dale; Cheryl Heber; Jeffrey Winters
Journal:  J Clin Apher       Date:  2020-07-08       Impact factor: 2.821

4.  Mechanisms of Action of Extracorporeal Photopheresis in the Control of Bronchiolitis Obliterans Syndrome (BOS): Involvement of Circulating miRNAs.

Authors:  Sara Bozzini; Claudia Del Fante; Monica Morosini; Hatice Oya Berezhinskiy; Sophia Auner; Elena Cattaneo; Matteo Della Zoppa; Laura Pandolfi; Rosalia Cacciatore; Cesare Perotti; Konrad Hoetzenecker; Peter Jaksch; Alberto Benazzo; Federica Meloni
Journal:  Cells       Date:  2022-03-25       Impact factor: 6.600

5.  Comparison of procedure times and collection efficiencies using integrated and multistep nonintegrated procedures for extracorporeal photopheresis.

Authors:  Wolfgang Mayer; Antonis Kontekakis; Christopher Maas; Ulrike Kuchenbecker; Susanne Behlke; Harald Schennach
Journal:  J Clin Apher       Date:  2022-02-28       Impact factor: 2.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.